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Abstract Proteomic profiling of human embryonic stem cells (hESC) can identify cell fate determination and
self-renewal biomarkers. Employing Fourier transform LC-ESI-MS/MS and MS3 mass spectrometry, we obtained a membrane
proteomic signature overlapping between hESC cultured on mouse embryonic fibroblast (MEF) feeders and those grown under
MEF-free culture conditions. We identified 444 transmembrane or membrane-associated proteins, of which 157 were common
between both culture conditions. Functional annotation revealed CD antigens (10%), adhesion proteins (4%),
proliferation-associated proteins (4%), receptors (41%), transport proteins (21%), structural proteins (5%), and proteins with
miscellaneous functions (15%). In addition, 15 CD antigens and a number of surface marker molecules not previously observed
in hESC at a proteome level, e.g., Nodal modulator 1, CD222, transgelin-2, and CD81, were identified. In conclusion, we
describe the first membrane proteome profile of hESC that is independent of culture conditions. These data can be used to
define the phenotype of hESC.
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One of the major issues facing the understanding of the
biology of human embryonic stem cells (hESC) and their use
in therapy is the absence of well-defined hESC-specific
markers that can be employed to ensure quality control of
hESC, to compare cell lines obtained from different labo-
ratories, and to identify differences between hESC lines
propagated under different culture conditions. Previous
studies have tried to identify a “molecular signature” of
hESC based on gene expression profiling (Abeyta et al., 2004;
International Stem Cell Initiative (ISCI), 2007; Laslett et al.,
2007; Sato et al., 2003). The first global transcriptional
profile of a single hESC line, the Wisconsin H1 cell line, grown.
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enriched in undifferentiated cells compared with differen-
tiated cells (Sato et al., 2003). Also, a comparison of H1 cells
to undifferentiated mouse embryonic stem cells showed
several genes expressed in common, suggesting the presence
of a core pluripotency program (Sato et al., 2003). In another
study, transcriptome analysis using Affymetrix oligonucleo-
tide microarrays of various, independently derived hESC
grown on mouse embryonic fibroblast feeders demonstrated
that the majority of genes expressed in hESC lines were
similar, but a small number showed a unique expression
profile, which could be explained only by either culture
conditions or intrinsic genetic differences (Abeyta et al.,
2004). A recent microarray study focusing on gene expression
profiles of early lineage committed hESC has reported that in
addition to genes associated with pluripotency, lineage-
specific transcription factors were coexpressed during early
differentiation stages (Laslett et al., 2007). Recently, the
International Stem Cell Initiative (ISCI, 2007) employed low-
density arrays and identified a common expression profile for
59 hESC lines. While these studies are useful, the identified
markers cannot provide a complete picture of the functional
proteins being expressed.
Mass spectrometry-based proteome analysis is a powerful
tool for identification of proteins by sequencing of peptides
from complex mixtures and has been employed to describe
the biological nature of a variety of cell types, including
adult stem cells (Adachi et al., 2007; Cox and Mann, 2007;
Foster et al., 2005). However, application of this technology
to hESC has been limited. Two studies have reported
proteome analyses of human embryonic stem cells using
whole-cell lysates. The first, a study by Baharvand et al.
(2006) employed 2D gel electrophoresis followed by MALDI
TOF/TOF mass spectrometry. The second study, by van Hoof
et al. (2006), employed 1D gel separation, in-gel digestion,
and LC-FTICR-MS/MS analysis. While these studies have
provided interesting data regarding the pluripotent pro-
teome profile of the cells, they were not directed toward
identification of new surface markers, since no specific
procedure was performed to enrich for membrane proteins.
Applying proteome analysis for the identification of novel
cellular surface markers to a reasonable proteome coverage
has, traditionally, been hampered by the poor probability of
obtaining peptides from low-abundance plasma membrane
(PM) proteins in a complex mixture. A previously published
PM isolation procedure from our group (Foster et al., 2005)
demonstrated its suitability for identifying novel low-
abundance surface markers of human mesenchymal stem
cells (hMSC). The aim of the current study was therefore to
apply the same methodology with modifications to obtain
low-abundance membrane proteins of hESC. Since hESC are
currently cultured under different in vitro conditions, we
wanted to identify a common proteome profile of hESC
independent of culture conditions. We employed hESC
populations obtained from two different but standard and
commonly employed culture conditions, feeder-containing
and feeder-free cultures, and we carried out membrane
proteome analysis using a method based on LC-ESI-FTICR-MS2
and MS3. Our data present a “membrane proteome profile”
of hESC, which provides insights into self-renewal programs
characteristic of hESC and identifies novel surface markers
characteristic of hESC.Results and discussion
Characterization of hESC-OD3
hESC-OD3 cells were grown successfully both on inactivated
mouse feeder cells and under feeder-free culture conditions,
forming colonies that expressed the pluripotency markers
Oct-4, Nanog, Sox2, Tra1-81, and alkaline phosphatase
(ALP), visualized by immunocytochemistry. Also, hESC-OD3
cells expressed Tra1-60, Tra1-81, and SSEA4 as demonstrated
by FACS analysis (Supplementary Fig. 1). In addition, the cells
expressed Oct4, Sox2, Nodal, ALP, and hTERT mRNA as
evidenced by RT-PCR. Similar expression levels were
observed in cells grown without feeders (data not shown)
and in hESC-HUES9 grown on inactivated feeders (Supple-
mentary Fig. 2). Analysis of Giemsa-banded hESC-OD3
chromosomes revealed a karyotype of 46XX inv(9)(q20) in
20 metaphase spreads. In addition, hESC-OD3 were able to
form embryoid bodies (EB) that contained cells from all three
germ layers as evidenced by immunocytochemical positive
staining for albumin and CK18 (endoderm), TUJ-1 (ecto-
derm), and CD31 and CD34 (mesoderm). hESC-OD3 obtained
from MEF feeder-cell cultures were able to form teratomas
when implanted under the kidney capsule and subcuta-
neously in NOD-SCID mice (Prokhorova et al., 2008). Data
showing the characterization from colony staining, flow
cytometry, karyotyping, and EB can be found in Supplemen-
tary Fig. 1. Side-by-side comparison of hESC-OD3 with a
commonly employed hESC line, HUES9 hESC, revealed similar
phenotypic characteristics (Supplementary Fig. 2).
Proteome analysis and functional classification of
the membrane fraction
The Mascot search engine initially matched sequenced
peptides to 3133 protein identifications before data valida-
tion. Following validation by the MSQuant program (for
criteria see Materials and Methods), we obtained a total of
1075 proteins (539 nonredundant proteins detected in the
hESC–MEF and 536 in the hESC–MG populations). Filtration of
the 1075 proteins for membrane and cell surface proteins
resulted in 240 proteins selective for the hESC–MEF fraction
and 204 proteins selective for the hESC–MG fraction, of
which 157 were found under both culture conditions (Fig. 1).
Manual clustering for cellular compartmentalization using
the SwissProt/UniProt and Ensembl databases of the unfil-
tered dataset provided information about the efficiency of
the membrane-enrichment procedure.
Seventy-seven percent of the proteins shared between
the hESC–MEF and the hESC–MG growth conditions were
integral membrane proteins, proteins with known or pre-
dicted membrane anchors, or membrane-associated pro-
teins, whereas the percentage of nuclear or nuclear
membrane-bound proteins was lower than 7% (Fig. 2a).
Common proteins detected under the hESC–MEF
and hESC–Matrigel conditions
We considered the group of 157 proteins shared between
hESC–MEF and hESC–MG as a potential profile of membrane
proteins independent of culture conditions. Functional
Figure 2 Subcellular protein distribution and functional
clustering of membrane-enriched fractions from the combined
hESC cluster. (a) The combined percentages of overlapping
proteins analyzed from the membrane-enriched fraction of hESC
cultured on a feeder layer of MEF or hESC cultured under feeder-
free conditions on Matrigel. Analysis using ProteinCenter
provided the subcellular distribution of proteins overlapping
both culture conditions. Annotation of cellular compartmenta-
lization was performed in ProteinCenter, applying the filter
definition “membrane and cell surface.” The pie chart shows
that 45% of proteins were identified with the plasma membrane
and 27% with the ER membrane or lumen, 3% were associated
with the Golgi membrane and 2% with the mitochondrial
membrane. 17% of proteins analyzed were cytosolic and 5%
were of nuclear origin. (b) A pie chart illustrating the functional
clustering of proteins found in the overlapping set. Analysis using
SwissProt, UniProt, and Ensembl for each individual protein
found in the combined group of overlapping proteins provided
functional clustering. 41% of proteins were clustered as
receptors, 21% as transport proteins, 10% as differentiation
antigens, 5% as structural proteins, 4% as adhesion proteins, and
4% as proteins associated with proliferation, and 15% had
miscellaneous functions.
Figure 1 Common and distinct proteins found in the proteo-
mic profile. A schematic diagram illustrating the overlap of
proteins found under the two culture conditions: human
embryonic stem cells cultured on a feeder layer of mouse
embryonic fibroblasts (hESC–MEF) or hESC cultured under
feeder-free conditions on Matrigel (hESC–MG). After validation
in MSQuant and filtration using ProteinCenter, 157 (54.7%)
proteins were found to be common to both profiles. Two groups
of proteins, which were not found common to both conditions,
were also identified, with 83 (28.9%) proteins found in the hESC–
MEF set and 47 (16.4%) in the hESC–MG set.
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several categories: 10% CD antigens, 4% adhesion proteins,
4% proliferation-associated proteins, 41% receptors, 21%
transport proteins, 5% structural proteins, and 15% proteins
with miscellaneous functions (Fig. 2b). Semiquantitation by
XIC (extracted ion current) scoring of the 157 overlapping
identifications revealed that the protein ratios compared
between the two culture conditions did not vary more than
15%. For this analysis we calculated the protein ratios for
proteins recurring in the double determinations of hESC–MEF
files and hESC–MG files, respectively, and generated the XIC
scores. Peptide ratios were calculated and then averaged to
a protein ratio and a standard deviation (SD) was determined
based on the double determinations. The average SD for the
protein ratios of the hESC–MEF files was 28.25% and for the
hESC–MG files was 33.25% (see Supplementary Fig. 3).
Average retention time standard deviation was also calcu-
lated for the hESC–MEF files (3.16%) and for hMSC–MG
(4.45%), indicating good machine performance (Fig. 3).
Values plotted show the changes in abundance between
corresponding peptides (Da×s) dividing integrated values of
hESC–MG over hESC–MEF for peptide pairs. Eighty-five
percent of proteins were found to decrease or increase by
100% with an estimated 30% variation (see Materials and
Methods), or twofold increase/decrease, in a semiquantita-
tive setting. Seven proteins (4.5%) were above the upper
limit and 15 (9.6%) were below, giving levels of inaccuracy
between the differences of the two states.
Identified proteins, along with their International Protein
Index (IPI) accession numbers, UniProt numbers, localiza-
tion, and function and, for the common protein set, XIC
values and relevant references have been provided in
Supplementary Table 1.
Cluster of differentiation antigens
CD antigens are cell surface molecules with a number of
functions, including ligands, receptors, transporters, andcell adhesion molecules. We identified 15 different CD
markers in the common profile: CD 8b, 9, 29, 36L2, 44, 66,
71, 81, 98, 107a, 147, 222, 298, 321, and 326. The known
biological functions of several of the identified CD markers
suggest an important role in early embryonic development.
CD107a or LAMP1 is thought to be involved in blastocyst
implantation (Weitlauf and Knisley, 1992). CD147, an IgG
family glycoprotein, is the regulatory subunit of the γ-
secretase complex, which may play a role in blastocyst
implantation (Ding et al., 2002). CD326 has functions related
to signaling, cell migration, proliferation, and differentia-
tion as well as adhesion. The interplay of CD326 with E-
Figure 3 XIC scoring from the combined group of common proteins. A graph illustrating XIC values of the 127 quantified, overlapping
proteins analyzed from themembrane-enriched fraction from hESC cultured on feeder layer of MEF or hESC cultured under feeder-free
conditions on Matrigel presented on a log-scale y axis. XIC scores were calculated directly by the MSQuant program (http://msquant.
sourceforge.net/).
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κB, c-myc, and E-FABP, provides a putative link for its
involvement in cell migration and cell signaling controlling
the hESC pluripotent state (Trzpis et al., 2007).
Among CD antigens not previously reported in hESC
proteomic profiles, we identified CD9 (cell adhesion) and
CD81 (16-kDa Leu 13 protein receptor), which aremembers of
the transmembrane 4 tetraspanins superfamily (Levy and
Shoham, 2005). Similar to other members of this superfamily,
these proteins are involved in diverse biological processes
including cell activation, cell proliferation, cell adhesion,
and motility. Specifically, CD9 and CD81 have been shown to
be essential in sperm–egg fusion to mediate fertilization
(Rubinstein et al., 2006). High levels of CD9 expression have
previously been detected at a transcriptional level in hESC
(Carpenter et al., 2004) and it has been reported as a marker
of stemness (Cai et al., 2006; ISCI, 2007). Interestingly, CD9
associates with the integrin β1 precursor (Rubinstein et al.,
1997), also known as CD29, which has previously been
described as a marker of undifferentiated hESC (Cai et al.,
2006), and has been described as essential for embryogenesis
(Rohwedel et al., 1998). Another molecule thought to be of
importance for hESC self-renewal is CD44, a hyaluronic acid
(HA) receptor. CD44 is a mediator of HA-induced proliferation
and it has been linked to implantation due to its expression in
early embryos (Gerecht et al., 2007). Other CD antigens
found with potential roles in implantation are CD66 and
CD298. CD66 has been linked to cellular growth, prolifera-
tion, and cell survival (Gray-Owen and Blumberg, 2006) and
has been postulated to be involved in blastocyst implantation
(Bamberger et al., 2006), while CD298 has been found to be
transcriptionally present in bovine embryos, with increasing
levels recorded between the two-cell and the blastocyst
stages (Goossens et al., 2007). We also identified IGF2R (IMP2
or CD222), which has previously been reported as a marker of
the transcriptional regulation of the stemness state in hESC
lines (Cai et al., 2006; ISCI, 2007). Recently, IGF-2 and FGF
have been reported to establish cooperatively the regulatory
stem cell niche of pluripotent hESC (Bendall et al., 2007).
Adhesion-related proteins
We identified seven adhesion proteins in the dataset,
representing 4.4% of the proteins classified. Among these
seven proteins, five were transmembrane and two had
multiple cellular localizations. Adhesion proteins are knownto mediate cell–cell or cell–matrix interactions as well as
playing a role in early development patterning. They may be
important in mediating the pluripotent state of hESC as
evidenced by the observation that single-cell suspension of
hESC usually leads to induction of hESC differentiation (Karp
et al., 2006; Sathananthan and Trounson, 2005) and that
plating efficiency of hESC without a matrix or feeders is low
(Ludwig et al., 2006). One of the adhesion proteins identified
was podocalyxin, a surface membrane glycoprotein with a
known transcriptional correlation to “stemness markers” (Cai
et al., 2006; ISCI, 2007). It has recently been demonstrated
that the purified 200-kDa podocalyxin binds to the Tra1-60
and Tra1-81 antibodies commonly used to define a human
embryonic stem cell (Schopperle and DeWolf, 2007). The
Na+/H+ exchanger regulatory factor-1 (NHERF-1) has been
shown to be a selective ligand of podocalyxin, regulating the
ability to block or enhance cell adhesion (Tan et al., 2006).
We identified some membrane-associated cell adhesion
molecules previously reported by van Hoof et al. (2006),
including DSG2 (desmoglein-2), RAC1 (Ras-related C3 botu-
linum toxin substrate), and ATP2A2 (putatively an isoform of
sarcoplasmic/endoplasmic reticulum calcium ATPase 2).
DSG2 is thought to be necessary for normal ES cell
proliferation and early embryonic survival (Eshkind et al.,
2002).
Proliferation-related proteins
Seven (4.4%) of the hESC–MEF and hESC–MG common proteins
were associated with cell proliferation (one nuclear, four
membrane, one ER, and one nontransmembrane (predicted in
TMHMM http://www.cbs.dtu.dk/services/TMHMM/). Two of
the membrane proteins have previously been reported: gly-
pican-4 and TXNDC1 (Van Hoof et al., 2006). The membrane-
associated proteins identified were glypican-4 (K-glypican),
CAP-1, TRAP-α, and TXNDC1 (thioredoxin-related transmem-
brane protein). Glypican-4 is a membrane-bound GPI-
anchored glycoprotein that binds heparan sulfate proteogly-
can that plays a role in developmental morphogenesis and has
been described as one of the 25 most significantly expressed
genes in hESC (Sperger et al., 2003). Most work on localization
and function of glypican-4 has been carried out after day E7.5
(mouse) of development and glypican-4 has been identified
during the development of the extraembryonic membranes
and gastrulation. The activity scope of growth factors and
morphogens, such as FGFs, BMPs, Wnts, hedgehogs, and IGFs,
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pluripotency, seems to be activated or determined by
glypicans (De Cat and David, 2001).
Receptors
Of the 64 proteins identified as belonging to the receptor
group (41%), 38 were identified as membrane associated.
Among the other proteins identified, 14 were found within
the cytoplasm, 3 in the nucleus, and 3 in the ER lumen; 1 was
secreted and 5 had miscellaneous predicted localizations.
Nineteen proteins identified in the membrane-associated
group have been reported previously (Van Hoof et al., 2006):
PGRMC1 (progesterone receptor membrane component 1),
SRPRB (signal recognition particle receptor subunit β),
RRBP1 (isoform 3 of ribosome-binding protein 1), CKAP4,
RAB11B, RAB5A, ATP1A1, RTN4 (reticulon-4), RAB14, FDFT1,
CLIC1, CDC42, CANX, ACSL3, RDH11 (retinol dehydrogenase),
FAM62A, RALA, LRRC59, and RPL7A. Some of these proteins
have been reported to play an important role in the biolo-
gical functions of hESC. For example, CDC42 is a plasma-
membrane-associated small GTPase known to be involved in
epithelial cell polarization and formation of filopodia
(SwissProt P60953-1). Also, ESC 3D differentiation of a
CDC42-null mouse exhibits defects in cell polarity, cell–cell
junctions, cavitation, and survival (Wu et al., 2007). CKAP4
(cytoskeleton-associated protein 4) is a transmembrane
receptor that has been reported as a receptor for the
frizzled-8 protein (Conrads et al., 2006), suggesting involve-
ment with Wnt signaling known to regulate embryogenesis.
Frizzled-8 is involved in cell proliferation and embryonic
development and is known to be expressed by hESC lines (Wei
et al., 2005). Another of the binding proteins detected was
connexin 43, a protein that had not previously been des-
cribed at the protein level in hESC. However, it has been
described at the transcriptional level as a stemness marker
(Cai et al., 2006). Cx43 is a major gap junction protein found
in various cells and plays an important role in intracellular
calcium signaling. It also plays an important role in the
formation of the extravillous trophoblast in the developing
embryo, contributing to proliferation and the invasive
phenotype of the cells (Nishimura et al., 2004).
Transporter proteins
This group includes proteins involved in the movement of
ions, small molecules, or macromolecules across the cell
membrane. Thirty-four proteins (21.5% of the total com-
bined group) were identified in this group, including 25
membrane-bound, 3 nuclear, 3 cytoplasmic, 1 present in cell
tight junctions, 1 in the ER lumen, and 1 within the Golgi
apparatus. Nineteen of these proteins have been identified
previously (Van Hoof et al., 2006), 13 of which were found to
have a membrane association. The majority of proteins
found in this group were from the Rab/Ras group. Rab
proteins are small GTPases involved in determining organelle
identity and participate in membrane fusion reactions. They
are well-known effector molecules for the regulation of
receptor tyrosine kinase activities. Ras and Rab proteins act
as molecular switches related to assorted networks of
tethering factors and GTPase activating proteins. Rab
proteins have also been interlinked via effector molecules,
suggesting coordination of protein transport within the
endomembrane system (Markgraf et al., 2007). We identifiedthe following members of this family: RAB1A, RAB1B, RAB5C,
RAB13, Ras-related protein RAB10, RAB5B, GTPase RAB14,
and Ras-related nuclear protein. Of these, 3 were not
located within the membrane (RAB1A, RAB13, and the Ras-
related nuclear protein). During gastrulation in zebrafish,
regulation of the cohesion of mesendodermal progenitor
cells by Wnt11 is mediated by RAB5C (Ulrich et al., 2005).
Other groups of proteins identified include 3 solute carriers,
solute carrier family 2 (which facilitates glucose transport),
solute carrier family 1 (a neutral amino acid transporter),
and solute carrier family 16 member 1 (SLC16A1); five
proteins associated with vesicle trafficking, VAMP3, VAMP-
associated protein B/C (VAPB), vesicle-trafficking protein
SEC22b (SEC22B), transmembrane EMP24 domain-containing
protein 10 precursor (TMED10), transmembrane EMP24
protein transport domain-containing 9 (TMED9), vesicle-
associated membrane protein-associated protein A isoform 2
(VAPA), and ADP ribosylation factor 1 (ARF1). Solute carrier
family 2 (also known as GLUT1 or SLC2A1) is thought to have a
role as a transporter of glucose in mouse ESC during
differentiation and embryonic development (Tonack et al.,
2006). SLC16A1 (MCT1) is differentially expressed during
development of the embryo and has been demonstrated to
have an important role in the regulation of pH and mono-
carboxylate transport prior to preimplantation. Glucose has
an implied role in the control of SCL16A1 expression (Jansen
et al., 2006). ARF1 operates in a group of proteins involved in
intracellular protein trafficking and has a suggested role in
cell adhesion-related processes. Deletion of ARF-related
protein 1 leads to embryonic lethality during early gastrula-
tion (Zahn et al., 2006).
Structural proteins
Nine proteins were classified as structural (5.6%) and only
three of the nine structural proteins were classified as
associated with membranes: myoferlin, a nonspecific alka-
line phosphatase inhibitor precursor, and Talin 1. The
remaining proteins were classified as cytoplasmic (4),
cytosolic (1), or in the ER lumen (1). Talin 1 plays a role in
cell proliferation and in the assembly of the extracellular
matrix. A study using undifferentiated mouse ESC showed
that Talin 1 is fundamental for the assembly of focal
adhesions and integrin β1 expression (Priddle et al., 1998).
Proteins with miscellaneous functions
We identified 24 (15.2%) proteins with diverse functions,
which could not be grouped into the above-mentioned main
categories. Twenty-three of the proteins have a membrane
association. These proteins are involved in a variety of
cellular processes including apoptosis, metabolic processes,
developmental processes, enzyme activity, and electron
transport. They include Erlin2, Erasin, cytochrome P450, a
Golgi apparatus protein synaptophysin-like 1, and ribophorin
1 (known to be differentially regulated by FGFs) (Tateossian
et al., 2004).
Correlation of the proteomic signature with the
transcription signature of hESC
Several of the known membrane-associated pluripotent
markers of hESC were not identified in our membrane
proteome profile. For example, TDGF1, GABRB3, FGF4 and 5,
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expressed on the hESC cell surface either as membrane-
associated or as transmembrane proteins and have previously
been demonstrated to be expressed at the mRNA level by
hESC and thus related to their stemness (Cai et al., 2006;
ISCI, 2007). On the other hand, many of the identified
membrane proteins have not been described by a global DNA
microarray screen (Abeyta et al., 2004; ISCI, 2007; Laslett et
al., 2007; Sato et al., 2003). The difference between our
data generated by proteomic analysis and the previously
reported gene expression array analysis may be due to
differences in protein turnover and regulation of the
abundance of cellular mRNA and proteins (Aebersold,
2003). Importantly, the choice of enzyme used for peptide
generation dictates the nature, number, and lengths of
peptides to be analyzed in the mass spectrometer. In this
study we have employed the endoproteinase Lys C enzyme.
Lys C cleaves at K residues and thus the K content of a protein
determines if fragments suitable for MS analysis are
generated. The proteins mentioned above have been cleaved
in silico (peptide-cutter, SwissProt) and found to generate
very few proper-size fragments (data not shown). We have
described similar differences between the membrane pro-
teome and the mRNA gene expression data of hMSC (Foster et
al., 2005). Thus, at this stage, using proteomic tools and DNA
microarrays should be considered complementary, as the
outcome of a proteome analysis cannot be predicted from
the mRNA gene expression levels.
Strengths of this study
In contrast to previous hESC proteome studies that employed
whole-cell lysate, we have chosen a subglobal proteomic
approach and PM proteome profiling to define a “proteomic
profile” of hESC. Also, in our study we have employed an
improved approach that facilitates detection of plasma
membrane protein-derived peptides as well as GPI-anchored
proteins and other low-abundance membrane-associated
proteins. In addition, we performed both MS2 and MS3
experiments using the Finnigan linear quadrupole ion trap–
Fourier transform (LTQ–FT) ICR mass spectrometer to
increase data quality and the certainty of protein identifica-
tion as estimated by reverse database searches. We
employed a reverse database search of our identifications
to reduce the number of false positive identifications from
the dataset (Schandorff et al., 2007), and we employed the
MASCOT search engine using a reversed database (revIPI
human) and imported the hits into MSQuant for identification
of false positive peptides. Average mass accuracy for our
study after calibration in MSQuant (CEBI in-house develop-
ment at http://msquant.sourceforge.net/) was 2.7 ppm
(Zubarev and Mann, 2007), in concert with accuracies given
in several high-quality reports of proteome analyses (Adachi
et al., 2007). Finally, we have quantified the relative protein
abundance for the overlapping identities and shown that
they are present at comparable levels.
Comparison of our identified proteins with proteins
reported in two previously published studies on hESC (Bahar-
vand et al., 2006; Van Hoof et al., 2006) revealed that the
highest degree of consensus between datasets was observed
for the proteins identified by the use of a strategy based on LC-
MS (Van Hoof et al., 2006; 56.8%) rather than a strategy basedon 2D gel and MALDI TOF/TOF (Baharvand et al., 2006; 10%).
Our study demonstrates that a plasma-membrane-based
proteomic approach is a more useful approach for identifica-
tion of a larger number of low-abundance proteins.
Limitations of this study
We have performed proteomic identification of membrane
proteins from hESC to study similarities in a filtered
membrane profile between two common methods of hESC
culture. Quantitative proteomic methods are available, e.g.,
SILAC (stable isotope labeling in cell culture) (Ong and Mann,
2005), and can provide absolute quantitation on differences
in proteome profiles among cells cultured under a variety of
conditions. Our study provides baseline quantitative guide-
lines needed to perform these experiments.
It is possible that some mouse peptides derived from the
feeder layer of MEF contaminated the proteome profile of
hESC–MEF. To obtain an estimate of the contribution of murine
peptides in the hESC–MEF and hESC–MG membrane proteins
and to evaluate if the sequence coverage of mouse proteins
was significantly higher in hESC–MEF compared to hESC–MG,
we tested the peptides of the same five highest scoring protein
hits that matched peptides (N30 per hit) under both condi-
tions. The five proteins chosen represented both high-
sequence-conserved proteins between human and mouse and
poor-sequence-conserved proteins. The sequence matching
was performed by finding the sequence coverage percentage
for the peptides identified, for the five chosen human proteins
and for theirmouse homologs. This was carried out both for the
MEF condition and for the MG condition. In all cases both for
MEF and MG, the sequence coverage was better for human
sequences than for mouse homologs, suggesting no significant
murine contribution to the membrane peptide population.
Conclusion
A comparison of common cell culture conditions used in hESC
growth studies (MEF-feeder and feeder-free) has given a
profile of 58.3% of proteins found in common under both
conditions. Of these 157 nonredundant proteins, 43% have
not previously been reported within a proteomic profile in
hESC lines. While the majority of these cell surface proteins
have previously been found to be associated with implanta-
tion or early fetal development, their roles in the main-
tenance of pluripotency or in guiding differentiation are yet
to be determined.
This report presents the first description and identifica-
tion of a semiquantitative membrane proteome profile using
high-accuracy peptide mass fingerprinting in hESC. Our study
provides an initial description of hESC membrane proteome
profiles and baseline data needed for future quantitative
proteomics studies in hESC.
Methods and materials
Establishment of hESC line OD3
Derivation and characterization of Odense 3 (hESC-OD3), an
in-house-derived human embryonic stem cell line, are des-
cribed in the supplementary methods and materials. The
225Membrane proteomic profiling of hESCpluripotent phenotype of hESC-OD3 has been compared side
by side with a standard hESC line: HUES9 (kindly provided by
D. Melton, Harvard) (Supplementary Fig. 2). hESC-OD3 cells,
routinely cultured on inactivated MEF feeders (here termed
hESC–MEF) in 15% KOSR/KO-DMEM, were transitioned to
Matrigel (made according to the manufacturer’s instruc-
tions; BD Biosciences, Europe) and MEF conditioned medium
(Xu et al., 2001), supplemented, daily, with 8 ng/ml hbFGF
(Invitrogen) for five passages (here termed hESC–MG).
Whenever wells were subconfluent, the cells were passaged
to either fresh Matrigel or feeder-coated wells. hESC from
each condition (20–30×106) were prepared separately for
proteomic studies by growth on MEF and on Matrigel. Cells
grown on MEF were detached following incubation with
trypsin–EDTA (Invitrogen) for 1 min. Cells grown on Matrigel
were mechanically dissociated.
Membrane isolation from hESC
hESC were harvested from six-well culture dishes by washing
with 1 ml ice-cold PBS (without Ca2+ and Mg2+) containing
EDTA-free protease inhibitor cocktail (Roche, Germany). The
cells were centrifuged at 500 rcf for 10 min at 4°C. The cell
pellet was resuspended using a pipette in 1 ml of ice-cold
lysis buffer (255 mM sucrose, 20 mM Hepes, 1 mM EDTA, pH
7.4, EDTA-free protease inhibitor cocktail; Roche). The cell
lysate was transferred to a glass homogenizer (Wheaton
Douncer) and subjected to 35 strokes with the tight piston.
The cellular debris was visually evaluated, microscopically,
to confirm that nuclei were intact and that the debris sizes
even. The membrane homogenate was transferred to two 2-
ml microcentrifuge tubes and centrifuged at 20,800 rcf for
10 min at 4°C to separate mitochondria and nuclei. The
supernatants were transferred to two pre-lysis buffer-
washed PC4 tubes (Hitachi Koki), placed in a S100AT6-0061
rotor (No.18), and centrifuged in a Sorvall RC M150 GX
ultracentrifuge at 245,000 rcf at 4°C for 2 h. After
centrifugation the supernatant contained the cytosol frac-
tion and the pellet contained the plasma membranes,
endoplasmic reticulum, and Golgi.
The membrane pellet was carbonate-washed by resus-
pension in 1 ml of ice-cold 100 mM Na2CO3 (with EDTA-free
protease inhibitors; Roche) and incubated on ice for 30 min
with careful, occasional vortexing. A 1PC tube (Hitachi Koki)
was prewashed with 100 mM Na2CO3, and the membrane
sample was then transferred into it. Plasmamembranes were
harvested by centrifugation at 100,000 rcf, 4°C, for 30 min in
a S150AT-0097 (No. 7) rotor (Sorvall). After centrifugation,
the membrane pellet was washed once with 25 μl of 500 mM
NH4CO3, without resuspension, and the supernatant removed
again. The procedure was repeated with 25 μl of 50 mM
NH4CO3 and the pellet was removed. The pellet was
resuspended in 6 M urea/2 M thiourea before reduction and
alkylation.
In-solution digest
Samples were solubilized in 6 M urea/2 M thiourea (pH 8.0)
and centrifuged for 10 min at 9300 rcf (Eppendorf 5415R) to
pellet any insoluble material. One microliter of 1 μg/μl
dithiothreitol in water was added for every 50 μg of sampleand incubated for 30 min at room temperature. One
microliter of 5 μg/μl iodoacetamide in 50 mM NH4HC03 was
added for every 50 μg of sample and incubated for 20 min (in
the dark) at room temperature. Lys C (Wako Pure Chemical
Industries) was added at a concentration of 5 μg/ml and
incubated overnight at room temperature.
Mass spectrometry
Manufacture of C18-StageTip for peptide isolation
The Empore Disk C18 (No. 2215, 3M, Minnesota, MN, USA) was
used. A small disk was transferred into a 250-μl pipette tip
(Bioclean).
Use of C18-StageTips for sample desalting and cleaning
The following mass-spectrometry-grade solvents were used
during peptide isolation: methanol, trifluoroacetic acid
(TFA), buffer A (0.5% acetic acid), and buffer B (80%
acetonitrile, 0.5% acetic acid). The digested peptide sample
was acidified with TFA. The C18-StageTip was conditioned
with 10 μl methanol and the liquid was pressed through at 50
μl/min using a 1-ml plastic fitted syringe. The StageTip was
equilibrated using 30 μl buffer A at 50 μl/min. The
appropriate volume of sample was loaded at 20 μl/min and
the StageTip was washed with 10 μl buffer A at 50 μl/min.
The sample was eluted with 10 μl buffer B at a rate of 10 μl/
min, dried in vacuum at 45°C to a volume of 1 μl, and diluted
1:8 with buffer A. The sample (6 μl) was loaded onto the
analytical column of the LC-MS/MS system.
Nanoflow LC-FTICR-MS2 and MS3
Nano-HPLC-MS/MS and MS3 experiments were performed on
an Agilent 1100 nanoflow system and analyzed by electro-
spray mass spectrometry on a Finnigan LTQ–FT mass spectro-
meter (Thermo Fisher, Bremen, Germany) fitted with a
nanoESspray ion source (Proxeon Biosystems A/S, Odense,
Denmark). Peptide mixtures were loaded onto the column
with a flow of 0.5 μl/min and eluted with a flow of 0.25 μl/
min with a gradient of 10–64% acetonitrile in 0.5% acetic acid
over a 140-min gradient with 1 million charges. The mass
spectrometer was operated in data-dependent acquisition
mode, with multiple charged peptides selected for fragmen-
tation. The three most intense precursor ions of a spectrum
were isolated for accurate mass measurement by SIM scans in
the ICR call and fragmented in the linear ion trap by collision-
induced dissociation. The most intense ions in every MS2
spectrum (above m/z=300) were isolated and further
fragmented (MS3 scan). Previously selected precursor ions
were dynamically excluded for 30 s.
Data analysis
Protein identification and validation
Proteins were searched against the IPI human database
and for false positive rate estimation against the IPI
human reverse database. This was performed using the
MASCOT search engine (Matrix Science, London, UK). Pep-
tides were verified and quantified in the MSQuant program
(Center for Experimental Bioinformatics, University of
Southern Denmark, in-house program; Peter Mortensen,
http://msquant.sourceforge.net/). Peptides were searched
226 L. Harkness et al.with carbamidomethyl as fixed modification and oxidized
methionine, N-acetylation, pyroglutamate, and deamida-
tion (arginine and glutamine) as variable modifications.
Initial mass tolerance for MS peak identification was set to
5 ppm on MS2 to 0.6 Da, and three missed cleavages were
allowed. Peptides fulfilling the following criteria were
accepted: MS2 score must be over 32 and peptides must
have a Lys C cleavage site (K) with a length of at least 7
amino acids. Peptides for which the y-ion or b-ion score was
at least 54 were accepted. Protein identification criteria
were based on a minimum of two peptides corresponding to
an accumulated MS2 score of at least 64 (p=0.0001) and/or
an MS3 spectrum with an MS3 score of at least 54
(pN0.0001); single peptide protein identification required
the same as the latter (Olsen and Mann, 2004). Protein
identifications were loaded into the ProteinCenter program
(Proxeon Biosystems A/S) and filtered by applying the filter
combination “membrane and cell surface.”
Classification and clustering of the subcellular localiza-
tion of 1075 proteins were based on annotations in the
SwissProt (http://www.expasy.org/sprot/), UniProt (http://
www.ebi.uniprot.org/index.shtml), and Ensembl (http://
www.ensembl.org/index.html) databases.
Semiquantitative rates estimatedby extracted ion currents
LC-FTICR RAW files were loaded into the MGFcombiner
program (Center for Experimental Bioinformatics, University
of Southern Denmark, in-house program; Peter Mortensen,
http://msquant.sourceforge.net/) searched in MASCOT and
quantified with no isotope labeling using the MSQuant
program. XIC values were retrieved directly for the
corresponding peptides m/z signals between the two states.
Standard deviations of same-condition intersample XIC rates
were calculated from noncombined files. For MEF files the
average SD was 28.25%, for MG files 33.25%. For SD
distributions of XIC rates for hESC–MEF and hESC–MG, please
see Supplementary Fig. 3. SDs are presented as percentages
of XIC rates for each protein for which this value was
retrievable. SDs were not retrievable for some proteins
owing to their either being identified in only one of the
technical replicate files or being identified in both technical
replicate files but not based on the same peptides. SDs were
calculated based on values for each peptide corresponding
between the same state, added and averaged to give the SD
for each protein.
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